Biostat RM shaking bioreactor and Biobrain
New user interface
Biostat RM has been renewed with a new control tower that adopts the automation platform Biobrain, which is suitable for commercial production using a shaking-type bioreactor. 【Features】 ▪ Accelerates the market launch of customer products ▪ Simple transition from process development to commercial production ▪ Flexible specifications for diverse manufacturing needs and culture styles ▪ High-precision process control ▪ Support system by technical personnel stationed in various countries
basic information
You can find the following information in the related catalog: ▪ Applications ▪ Technical specifications ▪ Order information ▪ Accessories
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Related Videos
catalog（13）
Download All Catalogs
News about this product（3）
-
[Sending recorded video] Microbial culture using a single-use culture device.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. As the number of pharmaceutical companies working on gene therapy and vaccines increases, the need for culture devices for microorganisms using single-use technology is becoming more and more critical. Sartorius has developed the Biostat STR MO to meet this demand. This webinar will introduce the features and application examples of Sartorius's first single-use culture device for microorganisms, the Biostat STR MO. [Seminar Overview] Date: May 18, 2023 (Thursday) from 3:00 PM (approximately 30 minutes) Webinar recorded broadcast [Japanese, free] We will send the recorded video and the download URL for related product materials to those who registered at a later date. *We apologize, but participation from other companies in the same industry and email addresses not affiliated with your organization is not permitted. Thank you for your understanding.
-
[Sending recorded video] Cutting-edge pDNA and AAV therapeutics: Comprehensive upstream process technology covering everything from process development to actual production.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. The development of therapeutics using viral vectors is showing strong activity, with over 30% market growth expected in the next decade. The targets for treatment are diverse, but identifying critical process parameters through process development has become an urgent issue. As the first of two webinars, we will introduce the Ambr series, a representative of process development systems in upstream processes, as well as single-use bag bioreactors up to 2000L for large-scale manufacturing, including examples of associated PAT products. *We sincerely apologize, but participation from email addresses other than those of your company or organization is not permitted. Thank you for your understanding.
-
"We will send you a recorded video" upgraded single-use bag bioreactor for process enhancement.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Since 2020, Sartorius has been continuously working towards process enhancement, and in February, we introduced two bioreactors using single-use bags as the completed form of the enhanced upstream process. We will present the full details of the bioreactor system that meets the needs of commercial production and automation, along with case studies, in this webinar. Related site: https://srtrs.info/r/d7yvo
